SCHEMBL6681460

SCHEMBL6681460

O=C(NNCc1ccccc1)N(S)C(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ TP53 P04637 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ CES1 P23141 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ HDAC6 Q9UBN7 3/20 0.41
▸ HDAC3 O15379 2/20 0.41
▸ HDAC1 Q13547 2/20 0.41
▸ HDAC8 Q9BY41 2/20 0.41
▸ HDAC7 Q8WUI4 1/20 0.41
▸ HDAC10 Q969S8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14860299 0.76 MEN1 (0.50) RAB9ANPC1TP53SMN1; SMN2HPGD
SCHEMBL14859889 0.76 SMN1; SMN2 (0.56) RAB9ANPC1TP53SMN1; SMN2HPGD
SCHEMBL27601024 0.75 NPC1 (0.71) RAB9ANPC1TP53SMN1; SMN2HDAC6
SCHEMBL9864970 0.74 SMN1; SMN2 (0.52) RAB9ANPC1SMN1; SMN2HPGDKMT2A
SCHEMBL24847549 0.73 CYP1A2 (0.54) RAB9ANPC1SMN1; SMN2MEN1CYP3A4
SCHEMBL1653407 0.73 CYP1A2 (0.54) RAB9ANPC1SMN1; SMN2MEN1CYP3A4
SCHEMBL14859165 0.73 ALDH1A1 (0.51) RAB9ANPC1TP53SMN1; SMN2MEN1
SCHEMBL14859818 0.71 NR1H4 (0.49) MAPK1HDAC6HDAC3HDAC1HDAC8
SCHEMBL22649147 0.70 HDAC3 (0.45) RAB9ANPC1MEN1KMT2AHDAC3
SCHEMBL4418820 0.70 LMNA (0.51) RAB9ANPC1SMN1; SMN2KDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0798292-B1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) 2004-11-03 — — EP disclosed
US-6534546-B1 Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-18 — — US disclosed
CN-1310169-A Anils with nitric oxide synzyme inhibiting function SHUGAI SEIYAKU K K (JP) 2001-08-29 — — CN disclosed
CN-1172473-A Aniline derivatives having nitric oxide synthase inhibitory activity CHUGAI PHARMACEUTICAL CO LTD (JP) 1998-02-04 — — CN disclosed
EP-0798292-A1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 1997-10-01 — — EP disclosed
Send feedback